High risk HPVs (human papillomaviruses) are causally involved in the development of cervical cancer. However, other factors, such as somatic genetic alterations also play a decisive role in malignant conversion of cervical keratinocytes. Mutations and chromosomal aberrations are known to in¯uence the pattern of gene expression. Therefore we used the recently developed RT ± PCR based method of dierential display of mRNAs to detect dierences in gene expression which correlate with tumorigenicity. Non-tumorigenic HPV16-immortalized human foreskin keratinocytes (HPK IA) were compared with their tumorigenic counterparts and 49 dierent genes were identi®ed which were either up-or downregulated. The identi®ed genes encode proteins of the cytoskeleton and the extracellular matrix, the nuclear splicing apparatus, transcription regulators and membrane-associated proteins. The expression pattern of all genes was also examined by RNA ± RNA in situ hybridization in biopsies of normal cervical epithelium, precancerous lesions and cancers. Two genes, C4.8 and C21.7, are of particular interest because their expression is upregulated in a subset of high grade precancerous lesions and in over 58% of cancers. These two genes may therefore be considered as putative progression markers. C4.8 is a new member of the transmembrane 4 (TM-4) protein family which includes tumor-associated antigens such as CD63 and TAPA-1, whereas C21.7 shows no signi®cant homologies to any known genes or proteins.
Introduction
The world wide incidence of cervical cancer is in the range of 5 ± 48 per 100 000 women. The lowest and highest rate is observed in Spain and Columbia respectively (Muir et al., 1987; Ponten et al., 1995) . It is generally accepted that cervical cancer arises from histopathologically de®ned precursor lesions referred to as high grade intraepithelial lesions (HSIL). These precursors lesions may either arise from human papillomavirus-(HPV) induced low grade lesions (LSIL) or directly from the HPV-infected epithelium Koutsky et al., 1992; Schiman, 1992) .
Clearly, infection with high-risk HPV types is a sine qua non component for the development of cervical cancer but the carcinogenic process itself is of multistep nature. This is not only evident by the long delay between HPV infection and malignant conversion of the target cell but also by the accumulation of cytogenetic abnormalities such as chromosomal imbalances, allel loss and structural aberrations which are characteristically observed in cervical cancer. These genetic alterations have also been observed in HSIL, albeit to a much lesser extend (Heselmeyer et al., 1996) .
The clinical value of HPV detection for screening for SIL has been shown in several studies (Reid et al., 1991; Cuzick et al., 1995; Schneider et al., 1996) . However, the majority of SIL identi®ed in screening programs regress spontaneously and identi®cation of progression markers is mandatory in order to avoid overtreatment. Viral markers such as presence of high risk HPVs (Herrington et al., 1996) ; virus load Nindl et al., 1996) , pertinent HPV detectability (Hildesheim et al., 1994; Londesborough et al., 1996) , or the presence of speci®c HPV genotype variants (Xi et al., 1995; Londesborough et al., 1996) are clinically not useful for predicting the progressive potential of SIL due to low positive predictive value.
Genetic hallmarks prognostic for the development of cervical cancer may be more valuable in this context. Mutations and chromosomal aberrations may in¯uence the expression of as yet unknown cervical cancerrelated genes. To take advantage of this possibility, we decided to use the recently developed RT ± PCR based method for dierential display of mRNAs to detect stable altered expression patterns which correlate with dierent stages of HPV-induced disease. By the use of several combinations of short arbitrary primers for reverse transcription and PCR, theoretically all mRNA species of a particular tissue or a given cell can be ampli®ed Liang et al., 1992 Liang et al., , 1993 . The procedure is semi-quantitative and permits the detection of dierentially expressed genes simply by comparing the PCR products of two RNA extracts.
In recent years several cell culture systems have been introduced to study the mechanism of the multistage carcinogenic progression of cervical cells. Oncogenic genital HPV types are capable of immortalizing human primary epithelial cells in culture (DuÈ rst et al., 1987; Pirisi et al., 1987; Tsutsumi et al., 1992; Woodworth et al., 1988) . This property is not shared with HPV6 or HPV11 which generally induce benign lesions only (Schlegel et al., 1988; Woodworth et al., 1989) . HPVimmortalized keratinocytes can acquire a malignant phenotype after transfection with an activated ras-oncogene or by a combination of gamma-irradiation and long term passage in culture or even long term passage alone (DuÈ rst et al., 1989 Chen et al., 1993) . For some of these cell lines genetic analyses were conducted by somatic cell fusion experiments. It was shown that the immortal and the tumorigenic phenotype of these cells are both recessive and that they are independent of each other (Chen et al., 1993; Seagon and DuÈ rst, 1994) . Moreover, we could show that the tumorigenic phenotype of one of our HPVimmortalized cell lines, HPK IA, could not be suppressed after fusion with cells of two dierent cervical carcinoma cell lines (MS751 and SiHa). This suggests that there may be a common genetic basis for HPV-related tumorigenesis. HPK IA cells may therefore serve to delineate the sequence of events involved in cell transformation 
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Northern blot hybridization B18 B17 B21 Figure 1 Identi®cation of dierentially expressed genes by DD ± PCR. The autoradiograph on the left shows PCR-products generated by using three dierent primer combinations. p49 and p359 refer to low passage non-tumorigenic and high passage tumorigenic HPK IA cells respectively. All reactions were done in dublicate. Bands characteristic for under-or overexpressed genes are shown in boxes. These bands were eluted from the gel, reampli®ed and used as hybridization probe for Northern blots in order to verify the DD ± PCR data. Transcripts of dierentially expressed genes are indicated by arrowheads. The reampli®ed PCRproducts B17 and B21 recognize several transcripts. This is due to the presence of more than one cDNA species after reampli®cation we identi®ed several genes that were either up-or downregulated in cells of the tumorigenic counterpart.
To assess the potential role of these genes in cervical carcinogenesis we also analysed the expression of these genes in normal cervical epithelium, premalignant lesions and cervical carcinomas.
Results
Identi®cation of dierentially expressed genes in nontumorigenic versus tumorigenic HPK IA cells
In order to identify genes whose altered expression correlates with the tumorigenic progression of HPK IA cells, we have used the technique of dierential display of mRNAs (DD ± PCR) recently described by Liang and Pardee (1992; Liang et al., 1992 Liang et al., , 1993 . Thirty-six dierent arbitrary 10mer primers were combined with nine de®ned anchoring primers (T12VV, V=A, C or G), resulting in 324 possible primer combinations for DD ± PCR. With few exceptions, all of these combinations produced characteristic and complex pattern of bands after electrophoretic separation in denaturing polyacrylamide gels. To ensure reproducibility, all PCR reactions including the RT reactions were performed in duplicate. More than 95% of all displayed bands were reproducible in independent experiments. On average 65 bands were obtained for each primer combination. Thus, in our study a total of about 21 000 cDNAs were ampli®ed and screened for changes in gene expression. Although not much is known about the intrinsic redundancy of this method, it is assumed that this number represents most of the mRNA-species expressed in a single cell (Liang and Pardee, 1995; Bauer et al., 1994) . A total of 252 dierentially expressed bands were excised, of which 230 were successfully reampli®ed. Prior to cloning of putative dierentially expressed genes, dierential gene expression was veri®ed by using the reampli®ed cDNAs as probes for Northern blot analyses (Figure 1 ). Of 230 reampli®ed PCR products only 70 showed evidence of dierential gene expression when comparing RNA from non-tumorigenic HPK IA cells with that of their non-tumorigenic counterparts. Frequently, hybridization resulted in the detection of several mRNA species (see Northern blots in Figure 1 for PCR products B17 and B21). This may be due to contamination of the hybridization probe with one or more additional cDNAs. Indeed, electrophoretic separation of excised cDNAs in native polyarcylamide gels showed that about one third of the reampli®ed cDNAs consisted of more than one band.
All Northern blots were repeated with cloned cDNA fragments as hybridization probes. Of 70 cloned cDNAs, 59 detected mRNAs which were dierentially expressed by a factor of two or more. Representatives of genes that are either up-or downregulated in the course of tumorigenic progression of HPK IA cells are shown in the left and right panel of Figure 2 respectively. Overall signal intensity varied strongly between dierent hybridization probes (exposure times ranging from 51 h to 42 weeks) indicating that abundant as well as rare mRNAs were detected by DD ± PCR. All cDNA clones representing dierentially expressed genes are listed in Table 1 . This table also gives an estimate of the size of the corresponding transcripts and the relative percentage by which the genes are either up-or downregulated in non-tumorigenic versus tumorigenic HPK IA cells.
DNA-sequence analysis of dierentially expressed genes
DNA sequence analysis and data base comparisons of all cloned cDNA fragments identi®ed 49 individual genes ( Table 2) . Because of the use of dierent primer combinations, some genes were identi®ed more than once. In most cases these cDNA clones represented overlapping sequences. Interestingly, this redundancy did not correlate with high steady state levels of the corresponding genes, since some of the genes such as MN1 (clones B17.3 and B39.11) or the MAL (clones B10.7 and B18.1) are only weakly expressed in HPK IA cells.
Forty cDNAs share sequence homologies of 498% with 30 known genes listed in DNA data bases and were therefore considered to be identical to these genes. The small sequence divergence observed for some clones may be explained by proofreading errors of the Taq DNA polymerase, reading errors and/or natural variance. One cDNA clone (clone D70.4) appears to represent the human homologue of the mouse or rat peptidylarginine deiminase gene. Two clones represent non-coding sequences homologous to human endogenous retroviral RNA (clones C37.2 and D97.7).
Fourteen cDNAs share identity with expressed sequence tags (ESTs) listed in the DNA data bases. Of these cDNAs, four show signi®cant homologies to known human genes or multigene families. For example, clones C4.8 and C19.6 are likely to represent two new members of the rapidly growing transmembrane-4 or TM4-multigene family. Clones D62,7 and F9,2 are highly homologous to a Na + -H + antiporter transmembrane protein and alpha-2 E-catenin, respectively.
Only ®ve cDNAs lacked identity with any of the DNA or protein sequences currently available from 4 kb 1.6 kb; 1.8 kb 3.7 kb 1.4 kb; 5.4 kb 3.6 kb 3.6 kb 3.2 kb 3.7 kb 7 kb; 8 kb 1.9 kb 4.7 kb; 4.5 kb 3.6 kb 3.6 kb 4.6 kb 3.7 kb 2.1 kb 9 kb; 10 kb 1.9 kb 1.7 kb; 5.6 kb 1.6 kb; 4.4 kb 1.3 kb 2 kb 8 kb; 9 kb 4.5 kb 7 kb 2.5 kb 1.6 kb 3.2 kb; 3.6 kb 1.9 kb 2 kb 1. Relative dierences in gene expression is indicated as follows: +*<10%; +*10 ± 30%; ++*30 ± 50%; +++ 100% data bases (Genbank, EMBL). These cDNAs are likely to represent novel human genes.
Dierential gene expression in premalignant cervical lesions and cancers
We have identi®ed a number of genes whose level of expression is altered when comparing non-tumorigenic HPK IA cells with their tumorigenic counterparts. In order to determine whether these alterations are also characteristic for any particular stage(s) of cervical carcinogenesis we have analysed the expression of these genes in normal cervical epithelium, high grade premalignant lesions (HSIL) and cervical cancers (three of each) by RNA ± RNA-in situ hybridization. Several cDNA probes A1.1/A6.9, A28.9, B17.3/B39.11, C9.2, C19.6, C25.6, C26.4, C30.8, C35.6, C48.8/C49.2, D5.8, D59.8, D83.8, E1.6, E2.10 and E8.2/F26 produced only weak or no hybridization signals in the tissues examined. Possibly these genes are expressed at levels beyond detection by in situ hybridization. Moreover, some hybridization probes (clones C9.2, C19.6, C25.5) gave rise to background problems i.e. no clear cut dierence between sense and antisense riboprobes. The remaining cDNA probes produced speci®c hybridization signals. The expression of these genes was therefore analysed in a second round of in situ hybridizations which comprised two normal epithelia, eight HSIL and 10 cervical carcinomas. In these analyses only a small number of genes (clones C4.8, C21.7, D85.5) showed (i) consistent expression in histologically identical tissues (ii) signi®cant up-or downregulation of gene expression (at least in a subset of biopsies) which correlated with disease progression. These results were again veri®ed in a third round of in situ hybridizations which included another 11 normal epithelia, 13 HSIL and 11 cervical cancers.
Of particular interest is clone C4.8 which is either expressed at low levels or not at all in normal cervical 98  97  95  97  98  100  99  97  99  99  96  98  98  99  ±  98  99  99  ±  97  99  ±  98  95  ±  99  99  98  99  98  99  87  87  98  93  98  98  98  96  100  100  92  98  99  100  98  99 epithelia. In contrast, 20 out of 24 cervical cancers including three out of three adenocarcinomas showed high levels of C4.8 transcripts (Figure 3) . Strong C4.8 expression was also observed for two out of eight cervical carcinoma cell lines (data not shown). Moreover, 10 out of 24 HSIL show moderate to high expression of this gene. Interestingly, in several high grade lesions C4.8 expression is restricted to small areas within the lesion (Figure 4 ). This may be indicative of a subpopulation of cells which may have reached a higher state of progression. Strong C4.8 expression is frequently found in normal appearing endocervical cells.
C21.7 is another gene whose expression is upregulated in a high percentage of HSIL (11/24) and in 14 out of 24 cervical carcinomas. In contrast, expression is either beyond the limit of detection or only weakly detectable in basal or suprabasal layers of all normal cervical epithelia examined ( Figure 5 ).
Striking changes of mRNA expression in cervical tumors compared to normal epithelia were observed for Collagen XII alpha 1 (clone D85.5). In all normal cervical epithelial tissues examined, collagen XII expression was predominantly localised to basal cells (Figure 6 ). With few exceptions (2/24), cervical cancers did not express this gene. However, in almost all cervical carcinomas analysed (21/24), collagen XII was strongly expressed in the stromal tissue directly adjacent to tumor cells (Figure 6 ). Hybridization signals were either arranged in a spot-like pattern which is characteristic for high steady state levels of RNA in single cells or the signals were uniformly distributed within the entire stromal tissue. Collagen XII also was expressed in the dermis of many highgrade lesions (13/24).
Discussion
The multistage process of carcinogenesis involves the dysregulation of a broad array of normal cellular functions including cell proliferation, DNA repair, chromosome stability, cell-cell communication, cellmatrix interactions, senescence, apoptosis, angiogenesis, tumor invasion and metastasis. This coincides with complex alterations of gene expression which are likely to be speci®c for particular cancer types. For example speci®c expression pro®les were described for pancreatic cancer (Gress et al., 1996) and gastrointestinal cancer (Zhang et al., 1997) . Also in breast cancer cell lines at least a hundred genes have been identi®ed whose expression is abolished or strongly downregulated (Sager et al., 1994; Sager, 1997) . In the case of cervical cancer, HPV speci®c oncoproteins are known to interact with several key regulatory proteins of the cell, thereby directly in¯uencing the cellular phenotype (Hoppe-Seyler and Butz, 1995) . However, to date no cellular gene(s) have been identi®ed whose altered regulation or function correlates with the malignant progression of cervical lesions.
We have identi®ed 49 dierent genes by the mRNA dierential display technique Liang et al., 1992 Liang et al., , 1993 whose expression is either upor downregulated when comparing non-tumorigenic HPV16-immortalized human keratinocytes (HPK IA) with their tumorigenic counterparts. As expected, the genes involved are very heterogeneous comprising at least ®ve dierent functional groups (Table 3) . A number of these genes are known to be associated with human disease. For example, MN1 (Buijs et al., 1995; , FKHR (Barr, 1997; Galili et al., 1993; Scheidler et al., 1996) and FUS/TLS (Aman et al., 1996; Calvio et al., 1995; Zinszner et al., 1997) are frequently aected by chromosomal translocations in malignancies. Others, such as Mi-2 (Seelig et al., 1995; Ge et al., 1995) , desmoplakin and calpastatin (Despres et al., 1995) are autoantigenic. While others are involved in regulating intracellular calcium concentrations or are themselves regulated by Ca 2+ -ions. In view of the diversity of genes aected it is dicult to assess which of these genes, if any at all, are related to HPV-induced carcinogenesis. We have therefore used in situ hybridization of biopsy material as a secondary screening method in order to determine whether any of these alterations in gene expression are also characteristic for the transition of premalignant cervical lesions to invasive carcinomas. Three genes are of particular interest, since their expression is consistently altered when comparing normal cervical epithelium with high grade lesions and cervical cancer. Moreover, in all three cases, the altered pattern of gene expression corresponds to that observed in our cell culture model system for HPV-induced tumorigenicity. In most cervical cancers and in a subset of high grade lesions the expression of C4.8 is strongly upregulated. This gene could therefore represent a potential marker for progression of high grade lesions. Data base analyses suggest that C4.8 is a novel human gene. Its DNA sequence has moderate, but signi®cant homologies to numerous members of the transmembrane 4 (TM-4) or tetraspan multigene family (Wright and Tomlinson, 1994; Figure 7 ). This family includes several lymphocyte surface antigens (CD37, CD53, CD9, CD82) and tumor-associated antigens (TAPA-1 or CD81, mrp-1 or CD63, T-cell acute lymphotropic leukemia antigen TALLA-1 or A15). The highest homology of C4.8 is shared with A15 (28% identity at amino acid level). Characteristic for all TM-4 proteins are four highly conserved membrane-spanning alpha-helical transmembrane domains. A highly heterogeneous putative extracellular domain of variable length is located between the third and the forth transmembrane region. Within this domain only minor motivs (e.g., a CCG tripeptide, and several cystein residues) are conserved. Clone C4.8 also shares similarity to other TM4-family genes from evolutionary very distant eucaryotic species such as the blood¯ukes Schistosoma mansoni and S. japonicum (sm23 cell surface antigen), and also has some homology to uroplakins. Beside clone C4.8, another novel member of the TM-4 family which is also dierentially expressed in HPK IA cells was identi®ed (clone C19.6). This cDNA also shares its highest homologies with the TALLA-1 tumor associated antigen (Takagi et al., 1995) but is distinct from clone C4.8. Unfortunately, no expression of this gene could be detected in cervical biopsies by RNA ± RNA-in situ hybridization.
The biological function of the TM-4 family proteins is largely unknown, but recently complexes of TM-4 family proteins with each other and cell surface integrins (Mannion et al., 1996; Berditchevski et al., 1996; Rubinstein et al., 1996) and phosphatidylinositol 4-kinase (Berditchevski et al., 1997) were described, thereby implicating a possible role in cell adhesion and cell signalling for members of this multigen family.
Another potential molecular progression marker is clone C21.7. This cDNA shares 97 ± 99% identity with several human expressed sequence tags. These show no signi®cant homologies to any known human genes. The sequence contains a polyadenylation signal (AUUAAA) and ends with a 12 bp polyA stretch (Figure 8) .
The third gene whose expression is signi®cantly altered during tumor progression is collagen XII alpha I (Gerecke et al., 1997) . Expression of this gene is restricted to the basal cells of the cervical epithelium. In contrast, in most cervical carcinomas collagen XII speci®c transcripts are not detectable by in situ hybridization. However, strong expression is detected in stromal tissue lining of most high grade lesions and most cervical cancers. Collagen XII expression is known to be upregulated in in¯ammatory tissue, bone resorption and regeneration, and wound healing (Berthod et al., 1997) . It is expressed in many tissues Our study underlines the use of cell culture model systems for HPV-induced tumorigenesis to de®ne molecular markers which may be speci®c for tumorigenic progression. We are currently preparing speci®c antibodies directed against the gene products of C4.8 and C21.7 in order to validate the potential use of these progression markers by immunohistochemical means. Moreover, the cloning of full-length cDNAs is underway in order to conduct functional analyses of these genes.
Materials and methods

Cell culture conditions
HPK IA cells were established by transfection of human foreskin keratinocytes with cloned DNA of the entire HPV16 genome and subsequent selection for unlimited growth in vitro (DuÈ rst et al., 1987) . HPK IA cells underwent tumorigenic conversion by a combination of girradiation and long-term propagation in vitro . Non-tumorigenic, early passage cells (passage p49) and tumorigenic, late passage HPK IA cells (p359) were grown as monolayer in Dulbecco's modi®ed eagle medium (D-MEM), supplemented with 10% fetal calf serum and the standard concentration of penicillin and streptomycin. To prevent¯uctuations in gene expression due to slight changes in cell culture conditions, the same batch of fetal calf serum was used when expanding HPK IA cells for the dierential display assay. Twenty four hours prior to RNA extraction cells were fed with fresh medium.
RNA extraction
HPK IA cells were grown to near con¯uency (90%) and total RNA was extracted by the guanidinium thiocyanate method (Chomczynski and Sacchi, 1987) . Prior to reverse transcription, RNA was DNase-treated with RQ1 RNasefree DNase (Promega) and its integrity was con®rmed by running 2.5 ± 5 mg of DNase-digested RNA on 1xMOPS formaldehyde-agarose gels (1%). RNA concentration was determined by spectrophotometry and adjusted to a concentration of 250 ng/ml. (Despres et al., 1995) Dierential display of mRNAs (RT ± PCR)
Dierential Display was basically performed as described by Liang and Pardee (1992; Liang et al., 1992 Liang et al., , 1993 . In brief, for reverse transcription (RT) one of nine dierent de®ned anchoring primers with a two-base anchoring sequence and a stretch of 12T bases was used (T 12 AA, T 12 AC, T 12 AG, T 12 CA, T 12 CC, T 12 CG, T 12 GA, T 12 GC, T 12 GG). Alternatively, the following 10mer arbitrary oligonucleotide primers were used: OPA 2 (TGG ATT GGT C); OPA 3 (CTT TCT ACC C); OPA 7 (TCG ATA CAG G); OPA 9 (TCG GTC ATA G); OPA 10 (GGT ACT AAG G); OPA 11 (TAC CTA AGC G); OPA 12 (CTG CTT GAT G); OPA 14 (GAT -CAA GTC C); OPA 15 (GAT CCA GTA C); OPA 16 (GAT CAC GTA C); OPA 25 (GAT CAT AGC G); OPA 26 (GAT CTAAGG C) (Bauer et al., 1994) . S]dATP was omitted to avoid possible contamination of the PCR machine by volatile radioactive products. Sucient amounts of radioactive label was incorporated to allow for short exposition times (overnight) of dierential display gels.
To con®rm that RNA samples used for dierential dispaly did not contain DNA contaminations, RT ± PCR was performed without reverse transcriptase. This invariably resulted in no or only very few bands. For each primer combination, PCR-ampli®cations were performed in duplicate using independent cDNA-preparations. By this approach the reproducibility of resulting PCR-fragment pattern could by veri®ed thereby minimizing the cloning of PCR artifacts at a later stage. Ampli®ed cDNAs were separated on 6% denaturing polyacrylamide gels. Radioactively labeled cDNA was visualized by exposing b-max Hyper®lm (Amersham) for 12 ± 36 h at room temperature. Alternatively, unlabelled PCR products were visualized by silver staining (Promega Silver staining kit).
Reampli®cation of PCR products from acrylamide gels
Dried gels and autoradiography ®lms were superimposed on each other by using Amersham TrackerTape (Amersham, England) and bands of interest were excised from the gels using sterile scalpels. For reampli®cation, these gel slices were placed directly into the PCR-reaction buer. Reampli®cation was performed using identical PCR conditions and primer combinations as before but without radioactive label and for 20 ± 25 cycles only. The reaction volume was increased to 50 ± 60 ml/PCR.
Reampli®ed cDNAs were separated in 1% agarose gel to estimate product size and yield. Reampli®cation of cDNA from silver stained acrylamide gels was limited to fragments of 400 bp or less. No size constraints were encountered when reamplifying radioactively labelled cDNAs. Generally, reampli®cation gave rise to a product of expected size but also to some minor contaminating fragments. The major band was excised and its DNA eluted using GenElute spin columns (Supelco). This DNA was of sucient quality for use in all subsequent experiments (DNA labeling by random priming, Northern hybridization, and cloning). Following gel purification, the composition and heterogeneity of the PCR-products was examined by separating 10 ± 50 ng of DNA on 6% native polyacrylamide gels.
In about one third of cases 2 ± 3 dierent PCR-products of slightly dierent size and/or gel-migration properties were evident. This indicated that not all contaminating fragments are removed by this strategy. This information was of importance when cloning the cDNA fragment of interest at a later stage.
Cloning of PCR products
Prior to cloning, dierential expression of the corresponding gene was con®rmed by using puri®ed, reampli®ed PCR-DNA as hybridization probe for Northern blots. For cloning, the pCR II vector (TA cloning kit, Invitrogen) was used. Alternatively, the ends of the PCR-products were blunted with T4 DNA polymerase and cloned into the SmaI restriction site of the pBluescribe (Stratagene). In cases in which reampli®cation of cDNAs gave rise to several fragment, 12 ± 24 colonies had to be screened in order to detect the cDNA of interest. After cloning Northern blots were repeated with excised inserts to con®rm the cloning of dierentially expressed genes.
Northern blot analysis
For Northern-blotting, 5 mg of heat denatured total RNA were separated on 1.2% agarose, 2.2 M formaldehyde/ MOPS denaturing gels, transferred to nylon membrane (GeneScreen Plus, DuPont NEN), and immobilized by U.V.-crosslinking (Stratalinker, Stratagene). cDNA probes for Northern blot hybridization were radioactively labeled by random primed DNA synthesis (Feinberg and Vogelstein, 1983 ) to a speci®c activity of 41610 8 c.p.m./mg DNA. Hybridization with house keeping genes like GAPDH (glyceraldehyde-phosphate dehydrogenase) or human cyclophilin were performed to ensure equal loading of RNA. Prehybridization buers consisted of 50% formamide, 56SSC, 50 mM sodium phosphate buer pH 6.6, 56Denhardt's solution, 0.1 mg/ml tRNA, 1% sodium dodecyl sulfate (SDS). For hybridization 3610 6 c.p.m./ml of Sephadex-G50 puri®ed radioactively labeled cDNA was added. Prehybridizations were performed at 428C for a minimum of 3 h; hybridizations at 428C for a minimum of 36 h. Filters were washed under stringent conditions for 3620 min in 26SSC, 0.1% SDS at 688C and exposed to X-OMAT AR-5 ®lms (Kodak) for 1 h to 10 days at 7808C.
DNA-sequencing and data base searching
Cloned cDNA fragments were sequenced from both sides using T7 DNA polymerase (T7 sequencing kit, Pharmacia Biotech); [a-35 -S]dATP (45000 Ci/mmol, Amersham), and standard M 13 sequencing primers. For some larger clones, internal primers were used for primer walking (clones C4.8, C21.7). Sequencing reactions were separated on 6 or 8% denaturing polyacrylamide sequencing gels. For sequence comparison, the UniGene, GeneBank, Swissprot, and EMBL databases were used. The programs BLASTN and FASTN (CGC program package, Genetics Computer Group Inc., Madison WI) and the Heidelberg UNIX Sequence Analysis Resource (HUSAR) were used for DNA sequence analysis, BLASTX and FASTX programs for analysis of protein sequences. Mapping data of known genes and expressed sequence tags (ESTs) to human chromosomes were retrieved from the UniGene database (Internet-access under http://www.ncbi.nlm.nih.gov/.) RNA ± RNA-in situ-hybridization of tissue sections Biopsies were taken from patients under colposcopic guidance (normal cervical epithelia and high grade cervical intraepithelial neoplasias (HSIL) and from patients undergoing radical hysterectomy (cervical carcinomas), immediately snap frozen in cold (7708C) 2-methyl-butane and stored in liquid nitrogen. Serial cryostat sections (5 mm) were mounted on 3-aminopropyl-triethoxysilane-coated slides, ®xed in 4% paraformaldehyde in 26SSPE for 10 ± 15 min at room temperature, digested with proteinase K (0.5 mg/ml) for 10 min at 378C, and prehybridized at 608C for 2 ± 4 h. Radioactively labeled, strand-speci®c riboprobes representing dierentially expressed genes were generated in pCR II cloning vector using SP6 and T7 RNA polymerases (NEB biolabs), 100 mCi [a-32 P]rUTP (800 Ci/ mmol, Amersham), and 250 mM rATP, rCTP and rGTP. After DNAse treatment, riboprobes larger than 150 bp were subject to limited alkaline hydrolysis. Hybridization was performed overnight at 608C in 50% formamide, 26SSPE, 10% dextran sulfate, 10 mM Tris-HCl pH 7.5; 16Denhardt's solution, 500 mg/ml tRNA, 100 mg/ml sonicated herring sperm DNA, 0.1% SDS, and 10 5 c.p.m. radioactive probe/ml. After hybridization, sections were washed once in 50% formamide, 26SSPE, 0.1% SDS for 30 min at 508C, treated with RNase A (50 mg/ml in 26SSC, 0.1% SDS) for 30 min at 378C, and washed again in 50% formamide, 0.56SSPE, 0.1% SDS for 30 min at 378C. Slides were dehydrated in graded alkohols, dried, dipped in ®lm emulsion (Kodak NTB 2, diluted 1 : 1 with 600 mM Ammonium acetate) and exposed for 7 ± 21 days at 48C.
